CdkL4 Antibody (X-18): sc-81840

CdkL4 Antibody (X-18) is a mouse monoclonal IgG1 kappa light chain antibody that detects CdkL4 protein of human origin by immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), and enzyme-linked immunosorbent assay (ELISA). Anti-CdkL4 antibody (X-18) is available as a non-conjugated monoclonal isotype antibody. CdkL4, or cyclin-dependent kinase-like 4, is a crucial protein that plays a significant role in the regulation of the cell cycle, specifically in the transition from the G1 phase to the S phase. This regulation is vital for proper cell division and growth, as dysregulation can lead to uncontrolled cell proliferation, a hallmark of cancer. CdkL4 is part of the CMGC Ser/Thr protein kinase family and consists of 315 amino acids. CdkL4 interacts with cyclins to form active complexes that phosphorylate target substrates, thereby driving the cell cycle forward. CdkL4 is implicated in transcription regulation and mRNA processing, highlighting its multifaceted role in cellular functions. Given its involvement in cell cycle control, anti-CdkL4 antibody (X-18) serves as an essential tool for researchers studying cell cycle dynamics and cancer biology.

Alexa Fluor^® is a trademark of Molecular Probes Inc., OR., USA

LI-COR^® and Odyssey^® are registered trademarks of LI-COR Biosciences

CdkL4 Antibody (X-18) References:

1. Cell cycle regulatory molecules (cyclins, cyclin-dependent kinases and cyclin-dependent kinase inhibitors) and the cardiovascular system; potential targets for therapy?  |  Li, JM. and Brooks, G. 1999. Eur Heart J. 20: 406-20. PMID: 10213344
2. Evolution of cyclin-dependent kinases (CDKs) and CDK-activating kinases (CAKs): differential conservation of CAKs in yeast and metazoa.  |  Liu, J. and Kipreos, ET. 2000. Mol Biol Evol. 17: 1061-74. PMID: 10889219
3. Cell cycle-dependent control of polarised development by a cyclin-dependent kinase-like protein in the Fucus zygote.  |  Corellou, F., et al. 2001. Development. 128: 4383-92. PMID: 11684672
4. Negative regulators of cyclin-dependent kinases and their roles in cancers.  |  Lee, MH. and Yang, HY. 2001. Cell Mol Life Sci. 58: 1907-22. PMID: 11766887
5. Role of the cyclin-dependent kinase inhibitors in the development of cancer.  |  Hirama, T. and Koeffler, HP. 1995. Blood. 86: 841-54. PMID: 7620180
6. The cell cycle kinases.  |  Pines, J. 1994. Semin Cancer Biol. 5: 305-13. PMID: 7803767
7. Cyclin dependent kinase regulation.  |  Lees, E. 1995. Curr Opin Cell Biol. 7: 773-80. PMID: 8608007
8. Cyclins, cyclin-dependent kinases and cdk inhibitors: implications in cell cycle control and cancer.  |  MacLachlan, TK., et al. 1995. Crit Rev Eukaryot Gene Expr. 5: 127-56. PMID: 8845581
9. Cyclin-dependent kinase regulation during G1 phase and cell cycle regulation by TGF-beta.  |  Ravitz, MJ. and Wenner, CE. 1997. Adv Cancer Res. 71: 165-207. PMID: 9111866